Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System.

Nonadherence to antiretroviral therapy (ART) jeopardizes good clinical outcome in people living with HIV. In a single-center prospective study, prevalence and correlates of nonadherence were investigated in 43 patients on ART. Nonadherence was assessed using Medication Event Monitoring System (MEMS), self-report and collateral report of treating physicians. Based on MEMS data, median taking adherence, dosing adherence, and timing adherence was 98% (interquartile range [IQR] = 5.3), 91.5% (IQR = 18), and 86% (IQR = 31.5), respectively. The median number of drug holidays per 100 days was 0.8 (IQR = 4.8). The prevalence of nonadherence measured by MEMS was 40%. Self-reported nonadherence and collateral report of nonadherence by physicians varied from 5% to 41% and 24% to 28%, respectively. Patients were categorized as adherent or nonadherent based on a clinically validated algorithm derived from MEMS parameters. Nonadherent patients used significantly more escaping coping strategies (p = 0.003) and planned problem solving strategies (p = 0.049), were prescribed significantly more antiretroviral medications (p = 0.02) and were significantly longer on ART (p = 0.04) than adherent patients. Identified correlates of nonadherence may help clinicians in detecting patients with HIV at risk for nonadherence and can support the development of adherence enhancing interventions.

[1]  M. Chesney,et al.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Moatti,et al.  Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART , 2001, HIV clinical trials.

[3]  Mardge H. Cohen,et al.  Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Wall,et al.  Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. , 2002, AIDS patient care and STDs.

[5]  M. Chesney,et al.  Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. , 2001, Journal of clinical epidemiology.

[6]  R. Remien,et al.  Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. , 2003, AIDS patient care and STDs.

[7]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[8]  Laura M. Bogart,et al.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[9]  Joseph W. Hogan,et al.  Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. , 2001 .

[10]  J. Stephenson.  AIDS researchers target poor adherence. , 1999, JAMA.

[11]  K A McKibbon,et al.  Interventions for helping patients to follow prescriptions for medications. , 2002, The Cochrane database of systematic reviews.

[12]  F. Maggiolo,et al.  Simpler Regimens May Enhance Adherence to Antiretrovirals in HIV-Infected Patients , 2002, HIV clinical trials.

[13]  S. Swindells,et al.  Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Jerome V. Murphy,et al.  Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center. , 2003, Archives of pediatrics & adolescent medicine.

[15]  M. Chesney,et al.  Nonadherence Among HIV‐Infected Injecting Drug Users: The Impact of Social Instability , 2002, Journal of acquired immune deficiency syndromes.

[16]  M. Chesney,et al.  Factors affecting adherence to antiretroviral therapy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  C. Koopman,et al.  Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. , 2003, AIDS patient care and STDs.

[18]  R. Rosenheck,et al.  Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  A. Wu,et al.  Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy: Overview of Published Literature , 2002, Journal of acquired immune deficiency syndromes.

[20]  J. Phair,et al.  Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. , 2001 .

[21]  D. Nicolau,et al.  Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Murphy,et al.  Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA , 2001, AIDS care.

[23]  P. Tsasis,et al.  Adherence assessment to highly active antiretroviral therapy. , 2001, AIDS patient care and STDs.

[24]  A. Wu,et al.  Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[25]  O. Elekwachi,et al.  Assessment and Predictors of Antiretroviral Adherence in Older HIV‐Infected Patients , 2003, Journal of acquired immune deficiency syndromes.

[26]  D. Skiest,et al.  Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  G. Powell-Cope,et al.  Predictors of self-reported adherence in persons living with HIV disease. , 1999, AIDS patient care and STDs.

[28]  D. Katzenstein,et al.  Characterizing patterns of drug‐taking behavior with a multiple drug regimen in an AIDS clinical trial , 1998, AIDS.

[29]  P. Pezzotti,et al.  Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group. , 1999, AIDS.

[30]  A. Wu,et al.  Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy , 2000, AIDS.

[31]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[32]  S. Folkman,et al.  Age differences in stress and coping processes. , 1987, Psychology and aging.

[33]  Richard D Moore,et al.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. , 2001 .

[34]  G. Wagner.  Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. , 2002, AIDS patient care and STDs.

[35]  I. Abraham,et al.  Measuring Transplant Patients' Compliance with Immunosuppressive Therapy , 1996, Western journal of nursing research.

[36]  J. Moatti,et al.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment , 2000, AIDS.

[37]  Joan A. Caylà,et al.  Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. , 2002 .

[38]  C. Hinkin,et al.  Medication adherence among HIV+ adults , 2002, Neurology.

[39]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.

[40]  S. Catz,et al.  Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease , 2001 .

[41]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[42]  D. Murphy,et al.  Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients , 2003, AIDS care.

[43]  A. Gifford,et al.  Chronic Disease Self‐Management and Adherence to HIV Medications , 2002, Journal of acquired immune deficiency syndromes.

[44]  M. Chesney,et al.  Adherence to HAART regimens. , 2003, AIDS patient care and STDs.

[45]  Julio S. G. Montaner,et al.  Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 109 cells/L , 2003, Annals of Internal Medicine.

[46]  A. Peterson,et al.  Meta-analysis of trials of interventions to improve medication adherence. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[47]  P. Moons,et al.  Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[48]  A. Carballo-Diéguez,et al.  Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples , 2002, AIDS care.

[49]  J. Simoni,et al.  Mediators of social support and antiretroviral adherence among an indigent population in New York City. , 2002, AIDS patient care and STDs.

[50]  B. Gazzard,et al.  Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. , 1998, AIDS.

[51]  M. Gill,et al.  Long-Term Patient Adherence to Antiretroviral Therapy , 2000, The Annals of pharmacotherapy.

[52]  R. Hays,et al.  A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors , 2001, Annals of Internal Medicine.

[53]  G. V. van Servellen,et al.  Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. , 2002, AIDS patient care and STDs.

[54]  A. Wu,et al.  Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[55]  B. Gazzard,et al.  Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors , 1998, AIDS.

[56]  J. Singer,et al.  Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. , 2002 .

[57]  D. Nau,et al.  Congruence of Three Self-Report Measures of Medication Adherence among HIV Patients , 2000, The Annals of pharmacotherapy.

[58]  P. Noto,et al.  Behavioral Correlates of Adherence to Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[59]  R. Grant,et al.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. , 2002 .

[60]  J. Moatti,et al.  Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. , 2002, Social science & medicine.

[61]  D. Vlahov,et al.  A PROSPECTIVE STUDY OF ADHERENCE AND VIRAL LOAD IN A LARGE MULTI-CENTER COHORT OF HIV-INFECTED WOMEN , 2002, AIDS.

[62]  D. Paterson,et al.  Measurement of Adherence to Antiretroviral Medications , 2002, Journal of acquired immune deficiency syndromes.

[63]  Judith A. Hall,et al.  Effectiveness of interventions to improve patient compliance: a meta-analysis. , 1998, Medical care.

[64]  F. Ceccherini‐Silberstein,et al.  Virologic Correlates of Adherence to Antiretroviral Medications and Therapeutic Failure , 2002, Journal of acquired immune deficiency syndromes.

[65]  A. Bandura.  Social Foundations of Thought and Action: A Social Cognitive Theory , 1985 .

[66]  A. Wu,et al.  Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[67]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[68]  K. Wong,et al.  Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients , 2003, HIV medicine.

[69]  T F Blaschke,et al.  Patient compliance and drug failure in protease inhibitor monotherapy. , 1996, JAMA.

[70]  B. Roca,et al.  Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients. , 2000, The Journal of infection.

[71]  J. Ward,et al.  Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. , 1999, AIDS.

[72]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[73]  A. Zolopa,et al.  High levels of adherence do not prevent accumulation of HIV drug resistance mutations , 2003, AIDS.

[74]  D. Kanouse,et al.  Adherence to HIV antiretrovirals among persons with serious mental illness. , 2003, AIDS patient care and STDs.

[75]  D. Nau,et al.  The relationship of disease severity, health beliefs and medication adherence among HIV patients , 2000, AIDS care.

[76]  J. Ware,et al.  The structure of psychological distress and well-being in general populations , 1983 .

[77]  J. Côté,et al.  Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. , 2003, The Journal of the Association of Nurses in AIDS Care : JANAC.

[78]  V. Soriano,et al.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. , 1999, AIDS.

[79]  R. Bolton,et al.  Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information. , 2002, AIDS patient care and STDs.

[80]  Allan J. Hance,et al.  HIV Drug Resistance , 2004 .

[81]  Howard Leventhal,et al.  The common-sense model of self-regulation of health and illness. , 2003 .

[82]  E. De Clercq,et al.  A Combination of Poor Adherence and a Low Baseline Susceptibility Score is Highly Predictive for HAART Failure , 2002, Antiviral chemistry & chemotherapy.

[83]  J R Ickovics,et al.  Adherence in AIDS clinical trials: a framework for clinical research and clinical care. , 1997, Journal of clinical epidemiology.

[84]  M. Burnier,et al.  Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions , 2001, Journal of hypertension.

[85]  E. van Wijngaerden,et al.  Nonadherence to highly active antiretroviral therapy: clinically relevant patient categorization based on electronic event monitoring. , 2002, AIDS research and human retroviruses.

[86]  M. Drachler,et al.  Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[87]  Fenguangzhai Song.  CD , 1992 .

[88]  K. Roberts.  Physician-patient relationships, patient satisfaction, and antiretroviral medication Adherence among HIV-infected adults attending a public health clinic. , 2002, AIDS patient care and STDs.

[89]  D A Hussar,et al.  Detection methods and strategies for improving medication compliance. , 1991, American journal of hospital pharmacy.

[90]  D. Richman,et al.  Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. , 2000 .

[91]  Joel E Gallant,et al.  Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  S. Geest,et al.  Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development. , 1994, Journal of advanced nursing.

[93]  D. Karus,et al.  Racial differences in attitudes toward protease inhibitors among older HIV-infected men , 2000, AIDS care.

[94]  Peter Sternhell,et al.  Psychiatric Morbidity and Adherence to Antiretroviral Medication in Patients With HIV/AIDS , 2002, The Australian and New Zealand journal of psychiatry.

[95]  B. Zomer,et al.  Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. , 2002 .

[96]  Sundhiya Mandalia,et al.  Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome , 2002, AIDS.